Table 1 Baseline MTC patient characteristics
Patient Characteristics | n = 98 |
|---|---|
Male | 45 (46) |
Age at diagnosis – median (range) | 54 (10-95) |
Genetic Mutation – no. (%) | |
FMTC or MEN 2 | 6 (6) |
Sporadic | 33 (34) |
Unknown | 59 (60) |
Local symptoms at presentation – no. (%) | |
Present | 85 (87) |
Not present | 12 (12) |
Unknown | 1 (1) |
Systemic symptoms at presentation – no. (%) | |
Present | 20 (20) |
Not present | 77 (79) |
Unknown | 1 (1) |
Clinical Stage at presentation - no. (%) | |
Stage I | 19 (19) |
Stage II | 26 (27) |
Stage III | 11 (11) |
Stage IVa | 25 (26) |
Stage IVb | 0 (0) |
Stage IVc | 12 (12) |
Unknown | 5 (5) |
Clinical SEER at presentation- no. (%) | |
Localized | 49 (50) |
Regional | 37 (38) |
Distant | 12 (12) |